2023 Q1 Form 10-K Financial Statement

#000149315223010295 Filed on March 31, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4 2022
Revenue $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.984M $2.057M $6.458M
YoY Change 138.76% 119.16% 130.08%
% of Gross Profit
Research & Development $333.9K $760.1K $2.281M
YoY Change -34.06% 54.52% 34.9%
% of Gross Profit
Depreciation & Amortization $212.1K $371.4K $647.7K
YoY Change 190.36% 1546.92% 2156.76%
% of Gross Profit
Operating Expenses $2.318M $2.817M $8.739M
YoY Change 73.32% 96.93% 94.3%
Operating Profit -$2.318M -$8.739M
YoY Change 73.32% 94.3%
Interest Expense $21.88K $5.399M $4.072M
YoY Change -108.91% -3323.92% -2542.27%
% of Operating Profit
Other Income/Expense, Net $206.0K -$3.432M $26.64K
YoY Change -171.77%
Pretax Income -$2.112M -$849.6K -$4.640M
YoY Change 12.95% -46.83% -0.53%
Income Tax
% Of Pretax Income
Net Earnings -$2.112M -$849.6K -$4.640M
YoY Change 12.95% -46.83% -0.53%
Net Earnings / Revenue
Basic Earnings Per Share -$0.20 -$0.57
Diluted Earnings Per Share -$0.20 -$0.10 -$0.57
COMMON SHARES
Basic Shares Outstanding 11.66M shares 9.407M shares 8.100M shares
Diluted Shares Outstanding 10.73M shares 8.100M shares

Balance Sheet

Concept 2023 Q1 2022 Q4 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $5.257M $4.171M $4.171M
YoY Change 1956.67% 181.98% 181.98%
Cash & Equivalents $5.257M $4.171M
Short-Term Investments
Other Short-Term Assets $123.4K $66.75K $66.75K
YoY Change 1663.14% 734.38% 734.38%
Inventory $546.7K $185.8K $185.8K
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $5.927M $4.423M $4.423M
YoY Change 1441.18% 174.89% 174.89%
LONG-TERM ASSETS
Property, Plant & Equipment $7.244M $7.005M $7.005M
YoY Change 83.86% 86.14% 86.14%
Goodwill
YoY Change
Intangibles $63.42K $62.48K
YoY Change
Long-Term Investments
YoY Change
Other Assets $359.8K $411.3K $411.3K
YoY Change -41.09% -22.37% -22.37%
Total Long-Term Assets $7.604M $7.416M $7.416M
YoY Change 67.09% 72.74% 72.74%
TOTAL ASSETS
Total Short-Term Assets $5.927M $4.423M $4.423M
Total Long-Term Assets $7.604M $7.416M $7.416M
Total Assets $13.53M $11.84M $11.84M
YoY Change 174.17% 100.59% 100.59%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $949.2K $854.7K $854.7K
YoY Change 11.36% 6.28% 6.28%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0% -100.0% -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.372M $2.007M $2.007M
YoY Change -28.28% -27.46% -27.46%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $2.372M $2.007M $2.007M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $2.564M $2.199M $2.199M
YoY Change -22.48% -20.52% -20.52%
SHAREHOLDERS EQUITY
Retained Earnings -$17.42M -$15.31M
YoY Change 43.49%
Common Stock $1.166K $941.00
YoY Change 81.31%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $10.97M $9.641M $9.641M
YoY Change
Total Liabilities & Shareholders Equity $13.53M $11.84M $11.84M
YoY Change 174.17% 100.59% 100.59%

Cashflow Statement

Concept 2023 Q1 2022 Q4 2022
OPERATING ACTIVITIES
Net Income -$2.112M -$849.6K -$4.640M
YoY Change 12.95% -46.83% -0.53%
Depreciation, Depletion And Amortization $212.1K $371.4K $647.7K
YoY Change 190.36% 1546.92% 2156.76%
Cash From Operating Activities -$2.063M -$2.042M -$6.433M
YoY Change 69.62% 71.21% 104.37%
INVESTING ACTIVITIES
Capital Expenditures $163.3K $2.538M $542.7K
YoY Change -801.13% -123.92%
Acquisitions
YoY Change
Other Investing Activities $0.00 $2.366M $209.7K
YoY Change -100.0% 22956.34% -379.57%
Cash From Investing Activities -$163.3K -$172.7K -$3.118M
YoY Change 308.18% -50.92% 33.03%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change -100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $3.239M 0.000 $12.24M
YoY Change 9865.26% -100.0% 136.19%
NET CHANGE
Cash From Operating Activities -$2.063M -2.042M -$6.433M
Cash From Investing Activities -$163.3K -172.7K -$3.118M
Cash From Financing Activities $3.239M 0.000 $12.24M
Net Change In Cash $1.086M -2.215M $2.692M
YoY Change -188.79% -280.15% -965.4%
FREE CASH FLOW
Cash From Operating Activities -$2.063M -$2.042M -$6.433M
Capital Expenditures $163.3K $2.538M $542.7K
Free Cash Flow -$2.226M -$4.580M -$6.976M
YoY Change 83.05% 451.34% 693.6%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001737995
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022Q4 us-gaap Notes Payable Current
NotesPayableCurrent
usd
CY2022Q4 STSS Contingent Stock Liability
ContingentStockLiability
usd
CY2022Q4 STSS Contingent Warrant Liability
ContingentWarrantLiability
usd
CY2021Q4 STSS Warrant Liability
WarrantLiability
usd
CY2021Q4 STSS Deferred Tax Liability
DeferredTaxLiability
usd
CY2022Q4 STSS Common Stock Subscription Receivable
CommonStockSubscriptionReceivable
usd
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
usd
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
usd
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
usd
CY2021 us-gaap Gain Loss On Sale Of Derivatives
GainLossOnSaleOfDerivatives
usd
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
usd
CY2021 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
usd
CY2022 STSS Stock Issued During Period Value Fractional Share Adjustment
StockIssuedDuringPeriodValueFractionalShareAdjustment
usd
CY2021 STSS Fair Market Value Adjustment For Contingent Stock
FairMarketValueAdjustmentForContingentStock
usd
CY2021 STSS Fair Market Value Adjustment For Contingent Warrants And Warrants
FairMarketValueAdjustmentForContingentWarrantsAndWarrants
usd
CY2021 STSS Ipo Issuance Costs Relating To Warrants
IpoIssuanceCostsRelatingToWarrants
usd
CY2021 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
usd
CY2022 STSS Payments To Acquire Other Assets Escrow Deposit
PaymentsToAcquireOtherAssetsEscrowDeposit
usd
CY2021 STSS Payments To Asset Acquisition
PaymentsToAssetAcquisition
usd
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
usd
CY2021 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
usd
CY2022 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
usd
CY2021 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
usd
CY2021 STSS Proceeds From Subscriptions Receivable
ProceedsFromSubscriptionsReceivable
usd
CY2021 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
usd
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2021 STSS Fmv For Common Stock Issued For Contingent Shares
FmvForCommonStockIssuedForContingentShares
usd
CY2021Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
usd
CY2021Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
usd
CY2022Q4 STSS Other Asset Acquisition
OtherAssetAcquisition
usd
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
usd
CY2021Q4 us-gaap Deposits Assets
DepositsAssets
usd
CY2021 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2021Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
usd
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
usd
CY2021Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
usd
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
001-41355
CY2022 dei Entity Registrant Name
EntityRegistrantName
Sharps Technology, Inc.
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
82-3751728
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
105 Maxess Road
CY2022 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 124
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Melville
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
11747
CY2022 dei City Area Code
CityAreaCode
(631)
CY2022 dei Local Phone Number
LocalPhoneNumber
574-4436
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2022 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Public Float
EntityPublicFloat
6203583 usd
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
11655936 shares
CY2022 dei Auditor Name
AuditorName
Manning Elliott LLP
CY2022 dei Auditor Location
AuditorLocation
Vancouver, Canada
CY2022 dei Auditor Firm
AuditorFirmId
1524
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4170897 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1479166 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
66749 usd
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7995 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
185804 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
121994 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
4423450 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
1609155 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7004890 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3763332 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
411316 usd
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
529863 usd
CY2022Q4 us-gaap Assets
Assets
11839656 usd
CY2021Q4 us-gaap Assets
Assets
5902350 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
854684 usd
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
804138 usd
CY2021Q4 us-gaap Notes Payable Current
NotesPayableCurrent
700015 usd
CY2021Q4 STSS Contingent Stock Liability
ContingentStockLiability
677000 usd
CY2021Q4 STSS Contingent Warrant Liability
ContingentWarrantLiability
585000 usd
CY2022Q4 STSS Warrant Liability
WarrantLiability
1151838 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2006522 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2766153 usd
CY2022Q4 STSS Deferred Tax Liability
DeferredTaxLiability
192000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
2198522 usd
CY2021Q4 us-gaap Liabilities
Liabilities
2766153 usd
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
1 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
1 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
1 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
1 shares
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9407415 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9407415 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5187062 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5187062 shares
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
941 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
519 usd
CY2021Q4 STSS Common Stock Subscription Receivable
CommonStockSubscriptionReceivable
-32500 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
24733306 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
13835882 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
214253 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-15307366 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-10667704 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
9641134 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
3136197 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
11839656 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5902350 usd
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2280933 usd
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1690865 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6457860 usd
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2806801 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
8738793 usd
CY2021 us-gaap Operating Expenses
OperatingExpenses
4497666 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-8738793 usd
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-4497666 usd
CY2022 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-1320416 usd
CY2021 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-166746 usd
CY2022 us-gaap Gain Loss On Sale Of Derivatives
GainLossOnSaleOfDerivatives
5392911 usd
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
26636 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-4639662 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-4664412 usd
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.57
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.96
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8100410 shares
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4876899 shares
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-4639662 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-4664412 usd
CY2022 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
214253 usd
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4425409 usd
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4664412 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
2130823 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-4664412 usd
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1571857 usd
CY2021 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
20000 usd
CY2021 STSS Stock Issued During Period Issuance Of Common Stock From Subscriptions Value
StockIssuedDuringPeriodIssuanceOfCommonStockFromSubscriptionsValue
3377929 usd
CY2021 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
200000 usd
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
500000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
3136197 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
3136197 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-4639662 usd
CY2022 STSS Stock Issued During Period Value Initial Public Offering
StockIssuedDuringPeriodValueInitialPublicOffering
8974657 usd
CY2022 STSS Stock Issued During Period Value Contingent Stock Liability
StockIssuedDuringPeriodValueContingentStockLiability
496000 usd
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1136638 usd
CY2022 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
290551 usd
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
214253 usd
CY2022 STSS Stock Issued During Period Collections Of Common Stock Subscriptions Value
StockIssuedDuringPeriodCollectionsOfCommonStockSubscriptionsValue
32500 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
9641134 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
9641134 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-4639662 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-4664412 usd
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
654572 usd
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
28699 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
1012592 usd
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
1195819 usd
CY2022 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
290551 usd
CY2021 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
20000 usd
CY2022 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1299985 usd
CY2021 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
159615 usd
CY2022 STSS Fair Market Value Adjustment For Contingent Stock
FairMarketValueAdjustmentForContingentStock
-181000 usd
CY2022 STSS Fair Market Value Adjustment For Contingent Warrants And Warrants
FairMarketValueAdjustmentForContingentWarrantsAndWarrants
-5211911 usd
CY2022 STSS Ipo Issuance Costs Relating To Warrants
IpoIssuanceCostsRelatingToWarrants
550433 usd
CY2022 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-496 usd
CY2022 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
58754 usd
CY2021 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-42005 usd
CY2022 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
34109 usd
CY2021 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
121994 usd
CY2022 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
12000 usd
CY2021 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
10262 usd
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-104352 usd
CY2021 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
202894 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6433159 usd
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3147736 usd
CY2022 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
209678 usd
CY2021 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
46900 usd
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
542662 usd
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2221830 usd
CY2021 STSS Payments To Acquire Other Assets Escrow Deposit
PaymentsToAcquireOtherAssetsEscrowDeposit
75000 usd
CY2022 STSS Payments To Asset Acquisition
PaymentsToAssetAcquisition
2365576 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3117916 usd
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2343730 usd
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
3377929 usd
CY2022 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
14202975 usd
CY2021 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
1802500 usd
CY2022 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
2000000 usd
CY2022 STSS Proceeds From Subscriptions Receivable
ProceedsFromSubscriptionsReceivable
32500 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
12235475 usd
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5180429 usd
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
7331 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2691731 usd
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-311037 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1479166 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1790203 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4170897 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1479166 usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
47111 usd
CY2021 us-gaap Interest Paid Net
InterestPaidNet
4000 usd
CY2022 STSS Fmv For Common Stock Issued For Contingent Shares
FmvForCommonStockIssuedForContingentShares
496000 usd
CY2022 STSS Fmv For Warrants Issued For Contingent Warrants
FmvForWarrantsIssuedForContingentWarrants
554312 usd
CY2022 STSS Common Stock Issued And Vested Stock Options For Fixed Assets Acquired
CommonStockIssuedAndVestedStockOptionsForFixedAssetsAcquired
63612 usd
CY2021 STSS Common Stock Issued And Vested Stock Options For Fixed Assets Acquired
CommonStockIssuedAndVestedStockOptionsForFixedAssetsAcquired
753336 usd
CY2022 STSS Common Stock Issued And Vested Stock Options Issued As Consideration For Acquisition
CommonStockIssuedAndVestedStockOptionsIssuedAsConsiderationForAcquisition
60435 usd
CY2021 STSS Common Stock Issued And Vested Stock Options Issued As Consideration For Acquisition
CommonStockIssuedAndVestedStockOptionsIssuedAsConsiderationForAcquisition
322701 usd
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_846_eus-gaap--UseOfEstimates_zOmOSmaLmFJ8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86D_zQ1BT2VVtsO2">Use of Estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates. As of December 31, 2022, the most significant estimates relate to derivative liabilities and stock-based compensation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 24.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0 usd
CY2021 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0 usd
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7004890 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3763332 usd
CY2022 us-gaap Depreciation
Depreciation
647690 usd
CY2021 us-gaap Depreciation
Depreciation
28699 usd
CY2022 STSS Remaining Payments Due On Machinery
RemainingPaymentsDueOnMachinery
100000 usd
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
9000000.0 usd
CY2022Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
106088 usd
CY2021Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
121994 usd
CY2022Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
49144 usd
CY2022Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
30572 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
185804 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
121994 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
7684614 usd
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3795366 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
679724 usd
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
32034 usd
CY2021Q4 STSS Other Asset Acquisition
OtherAssetAcquisition
472701 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
62480 usd
CY2022Q4 us-gaap Deposits Assets
DepositsAssets
336466 usd
CY2022Q4 STSS Other Non Current
OtherNonCurrent
12370 usd
CY2021Q4 STSS Other Non Current
OtherNonCurrent
57162 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
411316 usd
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
529863 usd
CY2022 us-gaap Adjustment For Amortization
AdjustmentForAmortization
6882 usd
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000 shares
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2019Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2019Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000 shares
CY2019Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q1 us-gaap Conversion Of Stock Description
ConversionOfStockDescription
Pursuant to the merger agreement, (i) the Company merged with and into Sharps Nevada, (ii) each 3.5 shares of common stock of the Company were converted into one share of common stock of Sharps Nevada and (iii) the articles of incorporation and bylaws of Sharps Nevada, became the articles of incorporation and bylaws of the surviving corporation
CY2022Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
5200000 usd
CY2022 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
290551 usd
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
500000 usd
CY2021 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
20000 usd
CY2022 us-gaap Payments For Repurchase Of Initial Public Offering
PaymentsForRepurchaseOfInitialPublicOffering
1121250 usd
CY2022 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
228750 usd
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.9347 pure
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0277 pure
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2022Q4 STSS Warrant Liability
WarrantLiability
1151838 usd
CY2022Q4 STSS Warrant Liability
WarrantLiability
1151838 usd
CY2022Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
9047795 shares
CY2022Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
9047795 shares
CY2022Q4 STSS Fair Market Value Of Note Warrants
FairMarketValueOfNoteWarrants
157647 usd
CY2022Q4 STSS Fair Market Value Of Trading And Overall Warrants
FairMarketValueOfTradingAndOverallWarrants
5778750 usd
CY2022Q4 STSS Fair Market Value Of Change In Fair Value Of Warrant Liability
FairMarketValueOfChangeInFairValueOfWarrantLiability
4784559 usd
CY2022Q4 STSS Warrant Liability
WarrantLiability
1151838 usd
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1137479 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.18
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
792857 shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.64
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
367500 shares
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.63
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
511764 shares
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
7.00
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
3571 shares
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
4.38
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
21875 shares
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
4.38
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
143286 shares
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
3.77
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
145157 shares
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
2.57
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1358122 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.37
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1137479 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.18
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1132861 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
4.59
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
825847 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
5.38
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.63
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
4.55
CY2022Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
475097 usd
CY2021Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
1260990 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
1012592 usd
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
1195819 usd
CY2022 STSS Stock Based Charges Relating To Purchase Of Machinery
StockBasedChargesRelatingToPurchaseOfMachinery
63612 usd
CY2022 STSS Stock Based Charges Relating To Acquisition
StockBasedChargesRelatingToAcquisition
60435 usd
CY2021 STSS Stock Based Charges Relating To Purchase Of Machinery
StockBasedChargesRelatingToPurchaseOfMachinery
253337 usd
CY2021 STSS Stock Based Charges Relating To Acquisition
StockBasedChargesRelatingToAcquisition
122701 usd
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.28 pure
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-974329 usd
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-979527 usd
CY2022 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
-859515 usd
CY2022 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-265607 usd
CY2021 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-311373 usd
CY2022 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-21965 usd
CY2021 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-57563 usd
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
2121416 usd
CY2021 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
1348463 usd
CY2022Q4 STSS Deferred Tax Assets Property Plant And Equipments
DeferredTaxAssetsPropertyPlantAndEquipments
-268594 usd
CY2021Q4 STSS Deferred Tax Assets Property Plant And Equipments
DeferredTaxAssetsPropertyPlantAndEquipments
3837 usd
CY2022Q4 us-gaap Deferred Tax Asset Interest Carryforward
DeferredTaxAssetInterestCarryforward
62310 usd
CY2021Q4 us-gaap Deferred Tax Asset Interest Carryforward
DeferredTaxAssetInterestCarryforward
46361 usd
CY2022Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
454942 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
917351 usd
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
637112 usd
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
2898411 usd
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
1687053 usd
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
921350 usd
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
536282 usd
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
37686 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
28985 usd
CY2021Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
28985 usd
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
5052441 usd
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
2939630 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
5244441 usd
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
2939630 usd
CY2022Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
192000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
4170897 usd
CY2022Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
4170897 usd
CY2022Q4 STSS Warrant Liability
WarrantLiability
1151838 usd
CY2022Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
1151838 usd
CY2022 STSS Order Costs To Purchase Equipment Molds And Component Parts For Research And Development
OrderCostsToPurchaseEquipmentMoldsAndComponentPartsForResearchAndDevelopment
609953 usd
CY2022 STSS Progress Payments
ProgressPayments
209678 usd

Files In Submission

Name View Source Status
0001493152-23-010295-index-headers.html Edgar Link pending
0001493152-23-010295-index.html Edgar Link pending
0001493152-23-010295.txt Edgar Link pending
0001493152-23-010295-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-k.htm Edgar Link pending
form10-k_001.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
form10-k_htm.xml Edgar Link completed
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
stss-20221231.xsd Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
stss-20221231_def.xml Edgar Link unprocessable
stss-20221231_cal.xml Edgar Link unprocessable
stss-20221231_pre.xml Edgar Link unprocessable
stss-20221231_lab.xml Edgar Link unprocessable